Dialysis News

• Kidney Transplant May Be Appropriate for Some With AL Amyloidosis In selected patients with light chain (AL) amyloidosis who are reaching end-stage renal disease (ESRD), kidney transplantation is a worthwhile approach, according to Boston-based researchers.
  Reuters Health Information, January 2019
• Flu at HF Hospitalization Ups Death, Renal, Respiratory Risks A new analysis documents just how much sicker an influenza infection can make patients who have been hospitalized with heart failure.
  Medscape Medical News, January 2019
• Scheduled Dialysis for Undocumented Immigrants Saves Money and Lives Providing scheduled dialysis for undocumented immigrants with kidney failure, rather than offering them only emergency dialysis, dramatically reduces deaths, healthcare use and costs, a study from Texas suggests.
  Reuters Health Information, December 2018
• Four-drug Combo Pill for HIV an Option in Chronic Dialysis Patients A daily single-tablet regimen of coformulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide, approved in the U.S. and elsewhere for HIV-1-infected patients with mild-to-moderate chronic kidney disease, may also work well in those with end-stage renal disease on chronic hemodialysis, a new study suggests.
  Reuters Health Information, December 2018
• Alfacalcidol Does Not Lower CV Risk in Dialysis, Trial Suggests Alfacalcidol did not reduce the risk for cardiovascular events in patients without secondary hyperparathyroidism who were undergoing maintenance hemodialysis, the J-DAVID trial found.
  Medscape Medical News, December 2018
• AHA 2018Closing Dialysis Fistula After Transplant Halts Cardiac Remodeling Arteriovenous fistula ligation in stable renal transplant recipients led to reduced LV mass and cardiac chamber size vs controls, with no harmful effects on graft function, in an early study.
  Medscape Medical News, November 2018
• AKI Shouldn't Preclude Kidney Donation, Study Shows Use of kidneys from deceased donors with acute kidney injury appears safe in multiyear follow-up and could make many more organs available for transplant, a study has found.
  Medscape Medical News, November 2018
• VAP-1 Inhibitor Shows Early Promise in Diabetic Kidney Disease ASP8232, a novel inhibitor of vascular adhesion protein-1 (VAP-1), reduces the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and chronic kidney disease, according to results from the ALBUM trial.
  Reuters Health Information, November 2018
• Uninsured Patients Experience Delays in Obtaining Arteriovenous Access for Hemodialysis Uninsured patients who start in-center hemodialysis with a central venous catheter are less likely than those already on Medicare or Medicaid to obtain arteriovenous fistulas (AVF) or grafts (AVG) by their fourth month of dialysis, when they become Medicare eligible, according to a new study.
  Reuters Health Information, November 2018
• ASTRO 2018SABR: Strong Contender for Treating Solitary Kidney Cancer Stereotactic ablative radiotherapy (SABR) provides good local control and causes minimal kidney damage in patients for whom preservation of kidney function is of paramount importance.
  Medscape Medical News, October 2018
• High-Dose Flu Vaccine More Effective for Patients on Dialysis Patients on dialysis who received a high-dose influenza vaccine were less likely to be hospitalized compared with those who received a standard-dose vaccine, a study found.
  Medscape Medical News, October 2018
• Early Dialysis Not Better for Septic Shock Patients With Acute Kidney Injury Early renal-replacement therapy for patients in the initial phase of septic shock who have severe acute kidney injury is no better than delayed therapy, according to a French study of 488 patients that was stopped early for futility.
  Reuters Health Information, October 2018
• Physician-Dialysis Clinic Joint Ventures Need Transparency Nephrologists who participate in a joint venture with dialysis companies should disclose that to their patients, experts argue.
  Medscape Medical News, October 2018
• Caffeine Linked to Lower Mortality in CKD A large observational study finds a significant inverse relationship between consuming caffeine and all-cause mortality among US patients with chronic kidney disease (CKD).
  Medscape Medical News, September 2018
• Patient Satisfaction Lower in Certain Dialysis Settings For-profit, freestanding, and large dialysis chains scored lower on patient satisfaction than their counterparts; an expert said the results are important, but further study is needed.
  Medscape Medical News, September 2018
• ESC 2018TRICS 3: Restrictive Transfusion Appears Safe in CV Surgery At what point do the risks of transfusion outweigh the risks of anemia? Is a hemoglobin threshold of 7.5 g/dL safe? Six-month findings of TRICS3 suggest this type of restrictive strategy is safe.
  Medscape Medical News, August 2018
• Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin 'I think this is the best data we have so far' supporting the use of apixaban in the especially high-risk population with atrial fibrillation, the lead researcher concludes. A randomized trial is forthcoming.
  Medscape Medical News, July 2018
• Canagliflozin Renal Outcomes Study Is Halted Early for Efficacy Hope that observed renoprotective effects of SGLT2 inhibitors will delay worsening of kidney disease in type 2 diabetes seems to be borne out, as the CREDENCE trial is stopped early.
  Medscape Medical News, July 2018
• HCV-Positive Kidneys Cost-Effective for HCV-Positive Recipients Quality-adjusted life expectancy is greater and costs are lower when kidney transplant candidates infected with hepatitis C virus (HCV) receive HCV-positive kidneys than when they receive HCV-negative kidneys, according to a cost-effectiveness analysis.
  Reuters Health Information, July 2018
• Rates of Lower Extremity Amputation Decline in Dialysis Patients Rates of lower extremity amputation declined over the past 15 years in Medicare patients with end-stage renal disease (ESRD) receiving dialysis, according to a new study.
  Reuters Health Information, July 2018